1. PD-1/PD-L1 pathway: current researches in cancer;Han;Am J Cancer Res,2020
2. PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome;Alsaab;Front Pharmacol,2017
3. Imfinzi (Durvalumab) Injection, for Intravenous Use [Prescribing Information];AstraZeneca Pharmaceuticals,2017
4. Ocular adverse events with immune checkpoint inhibitors;Fang;J Curr Ophthalmol,2019
5. Ocular adverse events in PD-1 and PD-L1 inhibitors;Young;J Immunother Cancer,2021